281 related articles for article (PubMed ID: 24674024)
1. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.
Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y;
Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024
[TBL] [Abstract][Full Text] [Related]
2. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
[TBL] [Abstract][Full Text] [Related]
3. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Salvia A; Samso JV; Lawrence C; Solomon J; Paul M; Lerman Y; Schwartzberg Y; Mordechai E; Rossini A; Fierro J; Lammens C; Malhotra-Kumar S; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M; Carmeli Y;
Clin Microbiol Infect; 2014 Aug; 20(8):O516-23. PubMed ID: 24450778
[TBL] [Abstract][Full Text] [Related]
4. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon.
Schaumburg F; Alabi A; Kokou C; Grobusch MP; Köck R; Kaba H; Becker K; Adegnika AA; Kremsner PG; Peters G; Mellmann A
J Antimicrob Chemother; 2013 Sep; 68(9):2140-3. PubMed ID: 23645586
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for colonization by Clostridium difficile and extended-spectrum β-lactamase-producing Enterobacteriaceae in rehabilitation clinics in Germany.
Arvand M; Ruscher C; Bettge-Weller G; Goltz M; Pfeifer Y
J Hosp Infect; 2018 Jan; 98(1):14-20. PubMed ID: 28705583
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
[TBL] [Abstract][Full Text] [Related]
7. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T
Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048
[TBL] [Abstract][Full Text] [Related]
8. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Zahar JR; Lesprit P; Ruckly S; Eden A; Hikombo H; Bernard L; Harbarth S; Timsit JF; Brun-Buisson C;
Int J Antimicrob Agents; 2017 Jan; 49(1):67-73. PubMed ID: 27890442
[TBL] [Abstract][Full Text] [Related]
9. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
Pilmis B; Cattoir V; Lecointe D; Limelette A; Grall I; Mizrahi A; Marcade G; Poilane I; Guillard T; Bourgeois Nicolaos N; Zahar JR; Le Monnier A
J Hosp Infect; 2018 Mar; 98(3):247-252. PubMed ID: 29222035
[TBL] [Abstract][Full Text] [Related]
10. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.
Ostholm-Balkhed A; Tärnberg M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A;
J Antimicrob Chemother; 2013 Sep; 68(9):2144-53. PubMed ID: 23674762
[TBL] [Abstract][Full Text] [Related]
11. Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors.
Papst L; Beović B; Seme K; Pirš M
Infect Dis (Lond); 2015 Sep; 47(9):618-24. PubMed ID: 25865350
[TBL] [Abstract][Full Text] [Related]
12. Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study.
Platteel TN; Leverstein-van Hall MA; Cohen Stuart JW; Thijsen SF; Mascini EM; van Hees BC; Scharringa J; Fluit AC; Bonten MJ
Clin Microbiol Infect; 2015 Feb; 21(2):141-6. PubMed ID: 25658554
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum β-lactamase Enterobacteriaceae.
Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD; Otter JA
Clin Microbiol Infect; 2017 Aug; 23(8):577.e1-577.e3. PubMed ID: 28242273
[TBL] [Abstract][Full Text] [Related]
14. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing enterobacteriaceae in rehabilitation wards in France.
Grall-Zahar I; Rucly S; Billard-Pomares T; Gasnier-Besnardeau K; Al Mouft O; Zahar JR; Zirnhelt I
Infect Dis Now; 2022 Oct; 52(7):403-407. PubMed ID: 35914711
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: A prospective study.
Angelin M; Forsell J; Granlund M; Evengård B; Palmgren H; Johansson A
Travel Med Infect Dis; 2015; 13(3):223-9. PubMed ID: 25982453
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
18. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Gniadkowski M; Hryniewicz W; Salvia A; Rossini A; Goossens H; Malhotra S; Lerman Y; Elenbogen M; Carmeli Y;
Clin Microbiol Infect; 2013 Feb; 19(2):E51-8. PubMed ID: 23210906
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors.
Shitrit P; Reisfeld S; Paitan Y; Gottesman BS; Katzir M; Paul M; Chowers M
J Hosp Infect; 2013 Nov; 85(3):230-2. PubMed ID: 24080081
[TBL] [Abstract][Full Text] [Related]
20. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
